Boya Chen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Cardiac Fibrosis and Remodeling
Papers in
-
- Genomics and Chromatin Dynamics 2
- Epigenetics and DNA Methylation 2
- Photosynthetic Processes and Mechanisms 2
- Histone Deacetylase Inhibitors Research 2
-
- Atrial Fibrillation Management and Outcomes 3
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Jie Du (6 shared papers)Yulin Li (4 shared papers)Congcong Zhang (3 shared papers)Luxin Liu (2 shared papers)Chunxiao Wang (1 shared paper)Xi A (1 shared paper)Bokang Qiao (2 shared papers)Jiao Yao (1 shared paper)
- Journals
- Molecular Therapy (1 paper)Expert Opinion on Drug Safety (1 paper)Acta Pharmaceutica Sinica B (1 paper)Patient Preference and Adherence (1 paper)Clinical Science (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Boya Chen
20 papers receiving 944 citations
Boya Chen's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 226
- Cardiology and Cardiovascular Medicine 229
- Molecular Biology 608
- Immunology 143
- Family Practice 12
Countries citing papers authored by Boya Chen
This map shows the geographic impact of Boya Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boya Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boya Chen more than expected).
Fields of papers citing papers by Boya Chen
This network shows the impact of papers produced by Boya Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boya Chen. The network helps show where Boya Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Boya Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury Hit paper breakdown → | 2017 | 330 |
| 2 | S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury Hit paper breakdown → | 2019 | 233 |
| 3 | 2018 | 90 | |
| 4 | 2022 | 80 | |
| 5 | 2018 | 40 | |
| 6 | 2017 | 35 | |
| 7 | 2018 | 34 | |
| 8 | 2017 | 25 | |
| 9 | 2022 | 17 | |
| 10 | 2024 | 13 | |
| 11 | 2024 | 13 | |
| 12 | 2013 | 10 | |
| 13 | 2016 | 10 | |
| 14 | 2024 | 4 | |
| 15 | 2016 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2017 | 1 |
About Boya Chen
Boya Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 22 papers that have together received 949 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (3 papers), Nanoplatforms for cancer theranostics (2 papers), Genomics and Chromatin Dynamics (2 papers), Epigenetics and DNA Methylation (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Photosynthetic Processes and Mechanisms (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (226 citations), Cardiology and Cardiovascular Medicine (229 citations), Molecular Biology (608 citations), Immunology (143 citations) and Family Practice (12 citations). Boya Chen has collaborated with scholars based in China and United States. Frequent co-authors include Jie Du, Yulin Li, Congcong Zhang, Luxin Liu, Chunxiao Wang, Xi A, Bokang Qiao, Jiao Yao, Xinying Yang and Yan Liu. Their work appears in journals such as Molecular Therapy, Expert Opinion on Drug Safety, Acta Pharmaceutica Sinica B, Patient Preference and Adherence and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.